Search

everythinglearnresearchcommunity

for

Search:↓

LGR5 mainly stays inside cells, moving to the trans-Golgi network, and this process is important for its role in cell signaling.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

ROOT HAIR SPECIFIC 10 (RHS10) reduces the length of root hairs in Arabidopsis plants.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

A mutant FERONIA gene affects root hair growth at high temperatures.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

VEGF stimulates hair cell growth and increases growth receptor levels through a specific signaling pathway.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

MIM is crucial for hair follicle formation and regeneration by controlling cilia formation and hedgehog signaling through its interaction with Cortactin and Src.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Exosomes from stem cells help hair regrowth by activating a specific signaling pathway.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Human liver cells stick to hair protein materials mainly through the liver's asialoglycoprotein receptor.

The SLICK1 allele in Holstein heifers affects hair and immune traits without altering prolactin signaling.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

ROR2 is essential for hair follicle stem cell renewal and maintenance.

Decorin, a protein, may help start hair growth and could be used to treat hair loss.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.